From metabolic disorders, auto-immune diseases, and cancer, there’s a commonality within each that has impacted patients’ wellness: their treatments utilize protein therapeutics. BioHybrid Solutions™ world-renowned scientists are spearheading innovations in protein therapeutics by solving a problem facing the pharmaceutical industry: How can we create longer-lived, more effective medicine? 

Our systematic in silico and in vitro process exerts  ImmunoControl™ through our  EpitopeSilencing™ process, improving pharmacokinetics and increasing the half-life of NanoArmored™ biologic therapeutics while maintaining activity. In addition, the ImmunoControl™ platform can be used for EpitopeTargeting™ and EpitopeAccentuation™ allowing for the discovery of new drugs against secondary, silent epitopes. 

BioHybrid Solutions™ is a partner to the U.S. Government and commercial biologic medicines development companies.

In the past six years, we have created a large number of custom NanoArmored™ proteins for a variety of therapeutics. Our proprietary technologies are currently being utilized to develop breakthrough biologic medicines that will meet the most critical needs for both civilian and military populations. Partnership opportunities are available. Contact us today.